APNHF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
2.51B
Intraday BUY SELL Signals
ORXOY
Price
$2.60
Change
-$0.40 (-13.33%)
Updated
Dec 17 closing price
Capitalization
103.34M
Intraday BUY SELL Signals
Interact to see
Advertisement

APNHF vs ORXOY

Header iconAPNHF vs ORXOY Comparison
Open Charts APNHF vs ORXOYBanner chart's image
Aspen Pharmacare Holdings
PriceLoading...
Change-$0.00 (-0.00%)
Volume$101
Capitalization2.51B
Orexo AB
Price$2.60
Change-$0.40 (-13.33%)
Volume$100
Capitalization103.34M
APNHF vs ORXOY Comparison Chart in %
ORXOY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APNHF vs. ORXOY commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHF is a Hold and ORXOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (APNHF: $6.23 vs. ORXOY: $2.60)
Brand notoriety: APNHF and ORXOY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APNHF: 100% vs. ORXOY: 33%
Market capitalization -- APNHF: $2.51B vs. ORXOY: $103.34M
APNHF [@Pharmaceuticals: Generic] is valued at $2.51B. ORXOY’s [@Pharmaceuticals: Generic] market capitalization is $103.34M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHF’s FA Score shows that 1 FA rating(s) are green whileORXOY’s FA Score has 0 green FA rating(s).

  • APNHF’s FA Score: 1 green, 4 red.
  • ORXOY’s FA Score: 0 green, 5 red.
According to our system of comparison, both APNHF and ORXOY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORXOY’s TA Score shows that 3 TA indicator(s) are bullish.

  • ORXOY’s TA Score: 3 bullish, 2 bearish.

Price Growth

APNHF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ORXOY (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +5.98%. For the same industry, the average monthly price growth was +12.50%, and the average quarterly price growth was +30.15%.

Industries' Descriptions

@Pharmaceuticals: Generic (+5.98% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHF($2.51B) has a higher market cap than ORXOY($103M). ORXOY YTD gains are higher at: 37.931 vs. APNHF (-49.122). APNHF has higher annual earnings (EBITDA): 2.16B vs. ORXOY (24.4M). APNHF has more cash in the bank: 6.41B vs. ORXOY (106M). ORXOY has less debt than APNHF: ORXOY (491M) vs APNHF (36.1B). APNHF has higher revenues than ORXOY: APNHF (43.4B) vs ORXOY (544M).
APNHFORXOYAPNHF / ORXOY
Capitalization2.51B103M2,440%
EBITDA2.16B24.4M8,857%
Gain YTD-49.12237.931-130%
P/E Ratio12.68N/A-
Revenue43.4B544M7,978%
Total Cash6.41B106M6,046%
Total Debt36.1B491M7,352%
FUNDAMENTALS RATINGS
APNHF vs ORXOY: Fundamental Ratings
APNHF
ORXOY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8046
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
n/a32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHF's Valuation (19) in the null industry is somewhat better than the same rating for ORXOY (73). This means that APNHF’s stock grew somewhat faster than ORXOY’s over the last 12 months.

APNHF's Profit vs Risk Rating (100) in the null industry is in the same range as ORXOY (100). This means that APNHF’s stock grew similarly to ORXOY’s over the last 12 months.

APNHF's SMR Rating (99) in the null industry is in the same range as ORXOY (100). This means that APNHF’s stock grew similarly to ORXOY’s over the last 12 months.

ORXOY's Price Growth Rating (46) in the null industry is somewhat better than the same rating for APNHF (80). This means that ORXOY’s stock grew somewhat faster than APNHF’s over the last 12 months.

APNHF's P/E Growth Rating (88) in the null industry is in the same range as ORXOY (100). This means that APNHF’s stock grew similarly to ORXOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APNHFORXOY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
40%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
40%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
47%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
17%
Bullish Trend 3 days ago
30%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
17%
Bearish Trend 3 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
ORXOY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDVVX25.180.08
+0.32%
JHancock Disciplined Value R5
DGFCX29.610.06
+0.20%
Davis Global C
JGSVX22.790.04
+0.18%
JPMorgan Small Cap Growth R5
AVEAX16.24N/A
N/A
Ave Maria Growth Focused
COICX17.93-0.03
-0.17%
Calvert International Opportunities C

APNHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, APNHF has been loosely correlated with GEDSF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if APNHF jumps, then GEDSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
GEDSF - APNHF
51%
Loosely correlated
N/A
ORXOY - APNHF
29%
Poorly correlated
N/A
QNTM - APNHF
4%
Poorly correlated
-8.14%
ORGO - APNHF
1%
Poorly correlated
+2.09%
YCBD - APNHF
1%
Poorly correlated
-4.22%
More

ORXOY and

Correlation & Price change

A.I.dvisor tells us that ORXOY and APNHF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORXOY and APNHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORXOY
1D Price
Change %
ORXOY100%
N/A
APNHF - ORXOY
28%
Poorly correlated
N/A
TKNO - ORXOY
8%
Poorly correlated
+0.24%
SEHCF - ORXOY
5%
Poorly correlated
N/A
GLASF - ORXOY
4%
Poorly correlated
-0.88%
HTSUY - ORXOY
0%
Poorly correlated
N/A
More